Surya Ramachandran
About Surya Ramachandran
Surya Ramachandran is a Program Scientist at the Rajiv Gandhi Centre for Biotechnology, where he has worked since 2012. He holds a PhD in Microbiology and has made significant contributions to cardiovascular research, including identifying cyclophilin A as a marker for vascular complications in type 2 diabetes.
Work at Oklahoma Medical Research Foundation
Surya Ramachandran worked as a Visiting Scientist at the Oklahoma Medical Research Foundation in 2012 for a duration of three months. This role contributed to his professional development and provided him with experience in a research-intensive environment.
Education and Expertise
Surya Ramachandran holds a Master of Science (MSc) in Microbiology from Manonmaniam Sundaranar University, completed from 1996 to 1998. He also earned a Doctor of Philosophy (PhD) in Microbiology with a focus on Oncology from the Regional Cancer Centre, studying from 2003 to 2008. Additionally, he achieved a Bachelor of Science (BSc) in Botany from the University of Kerala between 1993 and 1996. His educational background provides a strong foundation for his research in biological sciences.
Current Role at Rajiv Gandhi Centre for Biotechnology
Since 2012, Surya Ramachandran has been serving as a Program Scientist at the Rajiv Gandhi Centre for Biotechnology. His work focuses on research related to vascular complications and diabetes, contributing to significant advancements in the field over the past twelve years.
Research Contributions and Impact
Surya Ramachandran's research has garnered significant recognition, achieving 569 citations and a cumulative impact factor of 86.7. He identified cyclophilin A as a crucial marker for detecting vascular complications in type 2 diabetes through studies on secretory monocyte proteins. His work has implications for understanding cardiovascular diseases and diabetes.
Awards and Editorial Roles
Surya Ramachandran has received multiple accolades, including the ISHR-Torrent Young Investigator Award in 2017 and the ICMR National award for research in cardiovascular diseases. He serves as an editorial board member for the journal Molecular and Cellular Biochemistry and has reviewed articles for various scientific journals, contributing to the advancement of research in his field.